We are pleased to announce the addition of the Chief Strategy Officer role to our team, and the immediate appointment of Natasha Shumka to this key position. The CSO role holds great importance to Klonetics as it encompasses strategic planning, business development, regulatory compliance, market analysis, and cross-functional collaboration.
In her new role as CSO, Natasha will be responsible for shaping the long-term vision of the organization, identifying growth opportunities, and ensuring the facility's operations align with industry standards and regulations.
Natasha shared, “To me, the role signifies the crucial task of navigating the dynamic and evolving cannabis industry. It requires a deep understanding of the market, regulatory landscape, and emerging trends. The CSO plays a pivotal role in formulating strategies that drive the facility's success, enable it to adapt to changing market conditions, and maintain a competitive edge”
The CSO's responsibilities highlight the need for effective communication and collaboration with various stakeholders, both internal and external. By fostering strategic partnerships, managing relationships with investors and regulators, and promoting innovation, Natasha will contribute to the facility's growth and reputation within the industry.
In this newly created role, Natasha will touch on many aspects of the business at Klonetics and will manage a number of priority initiatives including, strategic planning, business development, regulatory compliance, market analysis and competitive intelligence, cross-functional collaboration, innovation and research, and stakeholder management.
Natasha will play a key role in shaping the future of Klonetics, and will directly drive the strategic direction and overall growth of the company.
Please join us in welcoming and congratulating Natasha Shumka to her new role as Chief Strategy Officer!
